Eagle Pharmaceuticals, inc. (EGRX)

[Bickema]

Something to note here is that Eagle's largest shareholder, Proquest, who had been very active selling shares recently and who acquired their original stake of 4.8 million shares in the IPO, hasn't sold a share since the day after Eagle announced the acquisition.

Maybe they have sold and haven't had to file yet? I am not sure on all the legalities on 13D's

Proquest Claims to have over $900 million in management, this would make their share in Eagle approx. 1/3 of their entire portfolio. I would expect them to continue selling shares at returns of over 500%.

Maybe I am looking to far into this...